The impact of COVID-19 on health care-associated infections in intensive care units in low- and middle-income countries : International Nosocomial Infection Control Consortium (INICC) findings
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved..
BACKGROUND: This study examines the impact of the COVID-19 pandemic on health care-associated infection (HAI) incidence in low- and middle-income countries (LMICs).
METHODS: Patients from 7 LMICs were followed up during hospital intensive care unit (ICU) stays from January 2019 to May 2020. HAI rates were calculated using the International Nosocomial Infection Control Consortium (INICC) Surveillance Online System applying the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC-NHSN) criteria. Pre-COVID-19 rates for 2019 were compared with COVID-19 era rates for 2020 for central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), mortality, and length of stay (LOS).
RESULTS: A total of 7,775 patients were followed up for 49,506 bed days. The 2019 to 2020 rate comparisons were 2.54 and 4.73 CLABSIs per 1,000 central line days (risk ratio [RR] = 1.85, p = .0006), 9.71 and 12.58 VAEs per 1,000 mechanical ventilator days (RR = 1.29, p = .10), and 1.64 and 1.43 CAUTIs per 1,000 urinary catheter days (RR = 1.14; p = .69). Mortality rates were 15.2% and 23.2% for 2019 and 2020 (RR = 1.42; p < .0001), respectively. Mean LOS for 2019 and 2020 were 6.02 and 7.54 days (RR = 1.21, p < .0001), respectively.
DISCUSSION: This study documents an increase in HAI rates in 7 LMICs during the first 5 months of the COVID-19 pandemic and highlights the need to reprioritize and return to conventional infection prevention practices.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:118 |
|---|---|
| Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 118(2022) vom: 01. Mai, Seite 83-88 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 28.04.2022 Date Revised 16.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijid.2022.02.041 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337504024 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337504024 | ||
| 003 | DE-627 | ||
| 005 | 20231225234546.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2022.02.041 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1124.xml |
| 035 | |a (DE-627)NLM337504024 | ||
| 035 | |a (NLM)35218928 | ||
| 035 | |a (PII)S1201-9712(22)00120-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rosenthal, Victor D |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The impact of COVID-19 on health care-associated infections in intensive care units in low- and middle-income countries |b International Nosocomial Infection Control Consortium (INICC) findings |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.04.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a BACKGROUND: This study examines the impact of the COVID-19 pandemic on health care-associated infection (HAI) incidence in low- and middle-income countries (LMICs) | ||
| 520 | |a METHODS: Patients from 7 LMICs were followed up during hospital intensive care unit (ICU) stays from January 2019 to May 2020. HAI rates were calculated using the International Nosocomial Infection Control Consortium (INICC) Surveillance Online System applying the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC-NHSN) criteria. Pre-COVID-19 rates for 2019 were compared with COVID-19 era rates for 2020 for central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), mortality, and length of stay (LOS) | ||
| 520 | |a RESULTS: A total of 7,775 patients were followed up for 49,506 bed days. The 2019 to 2020 rate comparisons were 2.54 and 4.73 CLABSIs per 1,000 central line days (risk ratio [RR] = 1.85, p = .0006), 9.71 and 12.58 VAEs per 1,000 mechanical ventilator days (RR = 1.29, p = .10), and 1.64 and 1.43 CAUTIs per 1,000 urinary catheter days (RR = 1.14; p = .69). Mortality rates were 15.2% and 23.2% for 2019 and 2020 (RR = 1.42; p < .0001), respectively. Mean LOS for 2019 and 2020 were 6.02 and 7.54 days (RR = 1.21, p < .0001), respectively | ||
| 520 | |a DISCUSSION: This study documents an increase in HAI rates in 7 LMICs during the first 5 months of the COVID-19 pandemic and highlights the need to reprioritize and return to conventional infection prevention practices | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Developing countries | |
| 650 | 4 | |a Health care–associated infection | |
| 650 | 4 | |a Hospital infection | |
| 650 | 4 | |a INICC | |
| 650 | 4 | |a Infection control | |
| 650 | 4 | |a Infection prevention | |
| 650 | 4 | |a International | |
| 650 | 4 | |a Low- and middle-income countries | |
| 650 | 4 | |a Nosocomial infection | |
| 650 | 4 | |a Surveillance | |
| 650 | 4 | |a nosocomial infection control consortium | |
| 700 | 1 | |a Myatra, Sheila Nainan |e verfasserin |4 aut | |
| 700 | 1 | |a Divatia, Jigeeshu Vasishtha |e verfasserin |4 aut | |
| 700 | 1 | |a Biswas, Sanjay |e verfasserin |4 aut | |
| 700 | 1 | |a Shrivastava, Anjana |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Ruzzieh, Majeda A |e verfasserin |4 aut | |
| 700 | 1 | |a Ayaad, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Bat-Erdene, Ariungerel |e verfasserin |4 aut | |
| 700 | 1 | |a Bat-Erdene, Ider |e verfasserin |4 aut | |
| 700 | 1 | |a Narankhuu, Batsaikhan |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Debkishore |e verfasserin |4 aut | |
| 700 | 1 | |a Mandal, Subhranshu |e verfasserin |4 aut | |
| 700 | 1 | |a Sengupta, Sankar |e verfasserin |4 aut | |
| 700 | 1 | |a Joudi, Hala |e verfasserin |4 aut | |
| 700 | 1 | |a Omeis, Ibrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Agha, Hala Mounir |e verfasserin |4 aut | |
| 700 | 1 | |a Fathallala, Amr |e verfasserin |4 aut | |
| 700 | 1 | |a Mohahmed, El Hossein |e verfasserin |4 aut | |
| 700 | 1 | |a Yesiler, Irem |e verfasserin |4 aut | |
| 700 | 1 | |a Oral, Mehmet |e verfasserin |4 aut | |
| 700 | 1 | |a Ozcelik, Menekse |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Yatin |e verfasserin |4 aut | |
| 700 | 1 | |a Sarma, Smita |e verfasserin |4 aut | |
| 700 | 1 | |a Chatterjee, Souranshu |e verfasserin |4 aut | |
| 700 | 1 | |a Belkebir, Souad |e verfasserin |4 aut | |
| 700 | 1 | |a Kanaa, Alaa |e verfasserin |4 aut | |
| 700 | 1 | |a Jeetawi, Rawan |e verfasserin |4 aut | |
| 700 | 1 | |a Mclaughlin, Samantha A |e verfasserin |4 aut | |
| 700 | 1 | |a Shultz, James M |e verfasserin |4 aut | |
| 700 | 1 | |a Bearman, Gonzalo |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Zhilin |e verfasserin |4 aut | |
| 700 | 1 | |a Yin, Ruijie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 118(2022) vom: 01. Mai, Seite 83-88 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
| 773 | 1 | 8 | |g volume:118 |g year:2022 |g day:01 |g month:05 |g pages:83-88 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2022.02.041 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 118 |j 2022 |b 01 |c 05 |h 83-88 | ||